Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group

BM Alexander; PD Brown; MS Ahluwalia; H Aoyama; BG Baumert; SM Chang; LE Gaspar; SN Kalkanis; DR Macdonald; MP Mehta; R Soffietti; JH Suh; Martin van den Bent; MA Vogelbaum; JS Wefel; EQ Lee; PY Wen

doi:10.1016/S1470-2045(17)30692-7

Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group

BM Alexander
, PD Brown
, MS Ahluwalia
, H Aoyama
, BG Baumert
, SM Chang
, LE Gaspar
, SN Kalkanis
, DR Macdonald
, MP Mehta
, R Soffietti
, JH Suh
, Martin van den Bent
, MA Vogelbaum
, JS Wefel
, EQ Lee
, PY Wen

Neurology

Research output: Contribution to journal › Article › Academic › peer-review

54 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	E33-E42
Journal	Lancet Oncology
Volume	19
Issue number	1
DOIs	https://doi.org/10.1016/S1470-2045(17)30692-7
Publication status	Published - 2018

Research programs

EMC OR-01

Access to Document

10.1016/S1470-2045(17)30692-7

http://hdl.handle.net/1765/103813

Cite this

Alexander, BM., Brown, PD., Ahluwalia, MS., Aoyama, H., Baumert, BG., Chang, SM., Gaspar, LE., Kalkanis, SN., Macdonald, DR., Mehta, MP., Soffietti, R., Suh, JH., van den Bent, M., Vogelbaum, MA., Wefel, JS., Lee, EQ., & Wen, PY. (2018). Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group. Lancet Oncology, 19(1), E33-E42. https://doi.org/10.1016/S1470-2045(17)30692-7

@article{67562b091b65470e9094012f96704a50,

title = "Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group",

author = "BM Alexander and PD Brown and MS Ahluwalia and H Aoyama and BG Baumert and SM Chang and LE Gaspar and SN Kalkanis and DR Macdonald and MP Mehta and R Soffietti and JH Suh and \{van den Bent\}, Martin and MA Vogelbaum and JS Wefel and EQ Lee and PY Wen",

year = "2018",

doi = "10.1016/S1470-2045(17)30692-7",

language = "Undefined/Unknown",

volume = "19",

pages = "E33--E42",

journal = "Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "1",

}

Alexander, BM, Brown, PD, Ahluwalia, MS, Aoyama, H, Baumert, BG, Chang, SM, Gaspar, LE, Kalkanis, SN, Macdonald, DR, Mehta, MP, Soffietti, R, Suh, JH, van den Bent, M, Vogelbaum, MA, Wefel, JS, Lee, EQ & Wen, PY 2018, 'Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group', Lancet Oncology, vol. 19, no. 1, pp. E33-E42. https://doi.org/10.1016/S1470-2045(17)30692-7

TY - JOUR

T1 - Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group

AU - Alexander, BM

AU - Brown, PD

AU - Ahluwalia, MS

AU - Aoyama, H

AU - Baumert, BG

AU - Chang, SM

AU - Gaspar, LE

AU - Kalkanis, SN

AU - Macdonald, DR

AU - Mehta, MP

AU - Soffietti, R

AU - Suh, JH

AU - van den Bent, Martin

AU - Vogelbaum, MA

AU - Wefel, JS

AU - Lee, EQ

AU - Wen, PY

PY - 2018

Y1 - 2018

U2 - 10.1016/S1470-2045(17)30692-7

DO - 10.1016/S1470-2045(17)30692-7

M3 - Article

C2 - 29304360

SN - 1470-2045

VL - 19

SP - E33-E42

JO - Lancet Oncology

JF - Lancet Oncology

IS - 1

ER -